News Article | April 17, 2017
LearnHowToBecome.org, a leading resource provider for higher education and career information, has released its list of the best colleges and universities in Colorado for 2017. 20 four-year schools made the list, with University of Denver, Regis University, Colorado School of Mines, University of Colorado—Colorado Springs and Colorado Colleges coming in with the highest scores. Of the 15 two-year schools that were also included, Aims Community College, Colorado Northwestern Community College, Trinidad State Junior College, Front Range Community College and Red Rocks Community College were the top five schools. A full list of schools is included below. “These schools have shown a commitment to preparing their students for success in college and beyond, with numbers to prove it,” said Wes Ricketts, senior vice president of LearnHowToBecome.org. “We measure data from each school, but also dig deeper into the success of alumni after college to find which colleges in Colorado truly are the best for students.” To be included on the “Best Colleges in Colorado” list, schools must be regionally accredited, not-for-profit institutions. Each college is also scored on additional data points including the number of career and academic resources, annual alumni earnings 10 years after entering college, financial aid availability, graduation rates and student/teacher ratios. Complete details on each college, their individual scores and the data and methodology used to determine the LearnHowToBecome.org “Best Colleges in Colorado” list, visit: Colorado’s Best Four-Year Colleges for 2017 include: Adams State University Colorado Christian University Colorado College Colorado Mesa University Colorado School of Mines Colorado State University-Fort Collins Colorado State University-Global Campus Colorado State University-Pueblo Fort Lewis College Johnson & Wales University-Denver Metropolitan State University of Denver Naropa University Regis University United States Air Force Academy University of Colorado Boulder University of Colorado Colorado Springs University of Colorado Denver University of Denver University of Northern Colorado Western State Colorado University Colorado’s Best Two-Year Colleges for 2017 include: Aims Community College Arapahoe Community College Colorado Northwestern Community College Community College of Aurora Community College of Denver Front Range Community College Lamar Community College Morgan Community College Northeastern Junior College Otero Junior College Pickens Technical College Pikes Peak Community College Pueblo Community College Red Rocks Community College Trinidad State Junior College ### About Us: LearnHowtoBecome.org was founded in 2013 to provide data and expert driven information about employment opportunities and the education needed to land the perfect career. Our materials cover a wide range of professions, industries and degree programs, and are designed for people who want to choose, change or advance their careers. We also provide helpful resources and guides that address social issues, financial aid and other special interest in higher education. Information from LearnHowtoBecome.org has proudly been featured by more than 700 educational institutions.
News Article | November 20, 2016
An analysis of collegiate graduate and post-graduate programs by AffordableCollegesOnline.org has determined the best places to earn a Master’s and Doctorate Degree Online in the nation for 2016-2017. As a leader in online higher education resources, the site measured cost and quality data to determine the top online programs for each degree level, identifying Western New Mexico University, Fort Hays State University, University of Central Arkansas, Arkansas State University and Wilmington University as the top scoring schools for earning an online master’s degree and the University of Colorado Denver, University of Mississippi, Indiana State University, University of Arkansas and Texas A&M University as the top scoring schools for earning an online doctorate degree. "As of 2013, over 23 percent of master’s and doctoral level students were completing their degrees entirely online,” said Dan Schuessler, CEO and Founder of AffordableCollegesOnline.org. "Our list pinpoints the schools around the nation who are providing students affordable, quality options when it comes to earning a post-baccalaureate degree, with the bonus of greater learning flexibility provided by online curriculum.” Schools must meet specific criteria to qualify for the Best Online Master’s Degree Programs & Best Online Doctorate Degree Programs lists. All institutions must be accredited, public or private not-for-profit entities and must offer in-state tuition and fees under $25,000 per year. Eligible institutions are further evaluated and scored based on a variety of data points, such as financial aid offerings, graduation rates and online program variety, to determine overall cost and quality rankings by school. Full rankings, as well as specific details on data and methodology used to determine school scores can be found at the following pages: All colleges highlighted for excellence in Online Master’s Programs for 2016-2017 are listed below: Adams State University Arkansas State University - Main Campus Ball State University Brenau University Chadron State College Columbus State University Concordia University-Saint Paul Delta State University East Carolina University Embry-Riddle Aeronautical University - Worldwide Emporia State University Fort Hays State University Graceland University - Lamoni Indiana State University Indiana Wesleyan University Liberty University Missouri State University - Springfield New Mexico State University - Main Campus North Carolina Central University North Carolina State University at Raleigh Northern Arizona University Northwestern State University of Louisiana Oklahoma State University - Main Campus Purdue University - Main Campus Saint Leo University Southeastern Oklahoma State University Southern Arkansas University Main Campus The University of Texas at Brownsville (University of Texas Rio Grande Valley) The University of Texas at Tyler Troy University University of Alabama at Birmingham University of Arkansas University of Arkansas at Little Rock University of Central Arkansas University of Central Missouri University of Colorado Denver University of Idaho University of Louisiana at Monroe University of Memphis University of Nebraska at Kearney University of North Carolina at Greensboro University of North Dakota University of Southern Mississippi University of West Alabama Wayland Baptist University Webster University Western Carolina University Western Kentucky University Western New Mexico University Wilmington University All colleges highlighted for excellence in Online Doctorate Programs for 2016-2017 are listed below: Allen College Amridge University Clemson University Colorado State University - Fort Collins Hampton University Harding University Indiana State University Kansas State University Keiser University - Fort Lauderdale Liberty University Mississippi State University Northern Arizona University Oregon State University Pennsylvania State University - Main Campus Rutgers University - New Brunswick Southern Illinois University - Edwardsville Stony Brook University Temple University Texas A & M University - College Station Texas A & M University - Commerce Texas Tech University The University of Alabama The University of Montana The University of Tennessee - Knoxville The University of Texas at Tyler The University of Texas Medical Branch Union Institute & University University at Buffalo University of Alabama in Huntsville University of Alaska Fairbanks University of Arizona University of Arkansas University of California - Berkeley University of Colorado Denver University of Delaware University of Florida University of Louisiana at Monroe University of Massachusetts - Amherst University of Michigan - Flint University of Minnesota - Twin Cities University of Mississippi University of Nebraska - Lincoln University of North Carolina at Chapel Hill University of North Carolina at Greensboro University of North Dakota University of Northern Colorado University of South Carolina - Columbia University of the Cumberlands Virginia Commonwealth University Wilmington University AffordableCollegesOnline.org began in 2011 to provide quality data and information about pursuing an affordable higher education. Our free community resource materials and tools span topics such as financial aid and college savings, opportunities for veterans and people with disabilities, and online learning resources. We feature higher education institutions that have developed online learning environments that include highly trained faculty, new technology and resources, and online support services to help students achieve educational and career success. We have been featured by nearly 1,100 postsecondary institutions and nearly 120 government organizations.
News Article | March 1, 2017
Late-Breaking Presentation Highlighting Interim Phase 2b Selinexor Data in Patients with Relapsed or Refractory DLBCL (SADAL Study) Overview of Key Selinexor Myeloma Data Also Featured at the 16th International Myeloma Workshop NEWTON, Mass., March 01, 2017 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, today announced that 12 abstracts describing the Company's product candidates in development for hematological and solid tumor malignancies have been selected for presentation at the 2017 Annual Meeting of the American Association for Cancer Research (AACR) taking place April 1-5, 2017 in Washington, DC. The abstracts, which represent both company- and investigator-sponsored studies, describe data related to Karyopharm’s lead product candidate, selinexor (KPT-330), an oral Selective Inhibitor of Nuclear Export / SINE™ compound, as well as two of its promising Phase 1 oncology programs, KPT-8602, a second-generation oral SINE compound, and KPT-9274, a first-in-class oral dual inhibitor of PAK4 and NAMPT. “The ongoing randomized Phase 2b SADAL study, which was initiated based on encouraging Phase 1 data in patients with diffuse large B-cell lymphoma (DLBCL), was designed to evaluate the overall response rate of single-agent oral selinexor in patients with relapsed or refractory DLBCL,” said Sharon Shacham, PhD, MBA, President and Chief Scientific Officer of Karyopharm. “We look forward to presenting interim results from this important trial at AACR this year.” Karyopharm is also presenting an overview of selinexor myeloma data at the 16th International Myeloma Workshop (IMW) held March 1-4, 2017 in New Delhi, India. In an oral presentation, titled “Oral Selinexor Shows Single Agent Activity Enhanced with PI or IMiD Combinations in Refractory Multiple Myeloma,” (Abstract #234) Sagar Lonial, MD, FACP, Professor and Chair, Hematology and Medical Oncology, Emory University, provided an overview of clinical data demonstrating selinexor’s activity in combination with proteasome inhibitors (PIs) and immunomodulatory drugs (IMiDs) for the treatment of relapsed or refractory multiple myeloma. The 2017 IMW is a prestigious biannual event where myeloma experts from around the world gather to discuss basic, preclinical and clinical aspects in the biology and treatment of multiple myeloma. Title: A Phase 2b randomized study of selinexor in patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL) demonstrates durable responses in both GCB and non-GCB subtypes Presenter: Marie Maerevoet, Institute Jules Bordet Poster Board #: 13 Session: Phase I-III Clinical Trials and Pediatric Clinical Trials Location: Convention Center, Halls A-C, Poster Section 33 Date and Time: Tuesday, April 4, 2017 from 1:00 PM - 5:00 PM Title: KPT-9274 inhibits cellular NAD and synergizes with doxorubicin to treat dogs with lymphoma Presenter: Cheryl London, Tufts University Poster Board #: 16 Session: Late-Breaking Research: Experimental and Molecular Therapeutics 2 Location: Convention Center, Halls A-C, Poster Section 34 Date and Time: Wednesday, April 5, 2017 8:00 AM - 12:00 PM Title: Selinexor or KPT-8602 mediated XPO1 inhibition synergizes with dexamethasone to repress convergent pathways in the mTORC1 signaling network and drive cell death in multiple myeloma Presenter: Christian Argueta, Karyopharm Therapeutics Inc. Poster Board #: 15 Session: Molecular and Cellular Biology/Genetics – Cell Growth Signaling Pathways 1 Location: Convention Center, Halls A-C, Poster Section 14 Date and Time: Sunday, April 2, 2017 1:00 PM - 5:00 PM Title: Novel role of XPO1 in regulating microRNAs related to pancreatic ductal adenocarcinoma invasion and metastasis Presenter: Asfar Azmi, Wayne State University Poster Board #: 5 Session: Molecular and Cellular Biology/Genetics – MicroRNA Regulation of Cancer Biology 1 Location: Convention Center, Halls A-C, Poster Section 19 Date and Time: Sunday, April 2, 2017 1:00 PM - 5:00 PM Title: Synergistic effects of the XPO1 inhibitor selinexor with proteasome inhibitors in pediatric high-grade glioma and diffuse intrinsic pontine glioma Presenter: John DeSisto, University of Colorado Denver Poster Board #: 18 Session: Tumor Biology: Pediatric Cancer 1: Biomarkers, Preclinical Models, and New Targets Location: Convention Center, Halls A-C, Poster Section 42 Date and Time: Monday, April 3, 2017 8:00 AM - 12:00 PM Title: Anti-tumor activity of selinexor is enhanced by palbociclib in preclinical models of HER2+ breast cancer Presenter: Hua Chang, Karyopharm Therapeutics Inc. Poster Board #: 12 Session: Experimental and Molecular Therapeutics – Combination Therapy 1 Location: Convention Center, Halls A-C, Poster Section 2 Date and Time: Monday, April 3, 2017 8:00 AM - 12:00 PM Title: Disruption of nuclear export with selinexor or KPT-8602 reduces androgen receptor expression and leads to potent anti-tumor activity in preclinical models of androgen-independent prostate cancer Presenter: Christian Argueta, Karyopharm Therapeutics Inc. Poster Board #: 13 Session: Endocrinology – Prostate Cancer Biology and Therapy Location: Convention Center, Halls A-C, Poster Section 25 Date and Time: Monday, April 3, 2017 8:00 AM - 12:00 PM Title: p21 activated kinase 4 (PAK4) as a novel therapeutic target for non-Hodgkin's lymphoma Presenter: Asfar Azmi, Wayne State University Poster Board #: 9 Session: Molecular and Cellular Biology/Genetics – Cell Growth Signaling Pathways 4 Location: Convention Center, Halls A-C, Poster Section 14 Date and Time: Monday, April 3, 2017 8:00 AM - 12:00 PM Title: Nuclear export of E2F7 in squamous cell carcinoma is an actionable event that reverses resistance to anthracyclines Presenter: Alba Natalia Saenz Ponce, University of Queensland, Brisbane, Australia Poster Board #: 28 Session: Experimental and Molecular Therapeutics: Reversal of Drug Resistance Location: Convention Center, Halls A-C, Poster Section 6 Date and Time: Monday, April 3, 2017 8:00 AM - 12:00 PM Title: Exportin-1 (XPO1) is a novel therapeutic biomarker for patients with neuroblastoma Presenter: Basia Galinski, Albert Einstein College of Medicine Poster Board #: 10 Session: Pediatric Cancer 1: Biomarkers, Preclinical Models, and New Targets Location: Convention Center, Halls AC, Poster Section 42 Date and Time: Monday, April 3, 2017 8:00 AM - 12:00 PM Title: Combined targeting of estrogen receptor alpha and nuclear transport pathways remodel metabolic pathways to induce apoptosis and overcome tamoxifen resistance Presenter: Eylem Kulkoyluoglu-Cotul, University of Illinois Urbana-Champaign Poster Board #: 14 Session: Endocrinology: Nuclear Receptors and Endocrine Oncology Therapies Location: Convention Center, Halls A-C, Poster Section 25 Date and Time: Tuesday, April 4, 2017 8:00 AM - 12:00 PM Title: Selinexor synergizes with DNA damaging agents through down-regulation of key DNA damage response genes Presenter: Trinayan Kashyap, Karyopharm Therapeutics Inc. Poster Board #: 26 Session: Experimental and Molecular Therapeutics – New Targets and New Drugs Location: Convention Center, Halls A-C, Poster Section 5 Date and Time: Tuesday, April 4, 2017 1:00 PM - 5:00 PM Selinexor (KPT-330) is a first-in-class, oral Selective Inhibitor of Nuclear Export / SINE™ compound. Selinexor functions by binding with and inhibiting the nuclear export protein XPO1 (also called CRM1), leading to the accumulation of tumor suppressor proteins in the cell nucleus. This reinitiates and amplifies their tumor suppressor function and is believed to lead to the selective induction of apoptosis in cancer cells, while largely sparing normal cells. To date, over 1,900 patients have been treated with selinexor and it is currently being evaluated in several mid- and later-phase clinical trials across multiple cancer indications, including in multiple myeloma in combination with low-dose dexamethasone (STORM) and backbone therapies (STOMP), and in diffuse large B-cell lymphoma (SADAL), and liposarcoma (SEAL), among others. Karyopharm plans to initiate a pivotal randomized Phase 3 study of selinexor in combination with bortezomib (Velcade®) and low-dose dexamethasone (BOSTON) in patients with multiple myeloma in early 2017. Additional Phase 1, Phase 2 and Phase 3 studies are ongoing or currently planned, including multiple studies in combination with one or more approved therapies in a variety of tumor types to further inform the Company's clinical development priorities for selinexor. The latest clinical trial information for selinexor is available at www.clinicaltrials.gov. Karyopharm Therapeutics Inc. (Nasdaq:KPTI) is a clinical-stage pharmaceutical company focused on the discovery and development of novel first-in-class drugs directed against nuclear transport and related targets for the treatment of cancer and other major diseases. Karyopharm's SINE™ compounds function by binding with and inhibiting the nuclear export protein XPO1 (or CRM1). In addition to single-agent and combination activity against a variety of human cancers, SINE™ compounds have also shown biological activity in models of neurodegeneration, inflammation, autoimmune disease, certain viruses and wound-healing. Karyopharm, which was founded by Dr. Sharon Shacham, currently has several investigational programs in clinical or preclinical development. For more information, please visit www.karyopharm.com. This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Such forward-looking statements include those regarding the therapeutic potential of and potential clinical development plans for Karyopharm's drug candidates, including the timing of initiation of certain trials and of the reporting of data from such trials. Such statements are subject to numerous important factors, risks and uncertainties that may cause actual events or results to differ materially from the Company's current expectations. For example, there can be no guarantee that any of Karyopharm's SINE™ compounds, including selinexor (KPT-330), KPT-8602 and KPT-9274, will successfully complete necessary preclinical and clinical development phases or that development of any of Karyopharm's drug candidates will continue. Further, there can be no guarantee that any positive developments in Karyopharm's drug candidate portfolio will result in stock price appreciation. Management's expectations and, therefore, any forward-looking statements in this press release could also be affected by risks and uncertainties relating to a number of other factors, including the following: Karyopharm's results of clinical trials and preclinical studies, including subsequent analysis of existing data and new data received from ongoing and future studies; the content and timing of decisions made by the U.S. Food and Drug Administration and other regulatory authorities, investigational review boards at clinical trial sites and publication review bodies, including with respect to the need for additional clinical studies; Karyopharm's ability to obtain and maintain requisite regulatory approvals and to enroll patients in its clinical trials; unplanned cash requirements and expenditures; development of drug candidates by Karyopharm's competitors for diseases in which Karyopharm is currently developing its drug candidates; and Karyopharm's ability to obtain, maintain and enforce patent and other intellectual property protection for any drug candidates it is developing. These and other risks are described under the caption "Risk Factors" in Karyopharm's Quarterly Report on Form 10-Q for the quarter ended September 30, 2016, which was filed with the Securities and Exchange Commission (SEC) on November 7, 2016, and in other filings that Karyopharm may make with the SEC in the future. Any forward-looking statements contained in this press release speak only as of the date hereof, and Karyopharm expressly disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.
News Article | February 23, 2017
The Community for Accredited Online Schools, a leading resource provider for higher education information, has ranked the best colleges with online programs in the state of Colorado. Among the schools that were ranked, 16 four-year colleges made the list, with University of Denver, Colorado State University Fort Collins, University of Colorado Boulder, University of Northern Colorado and University of Colorado Denver coming in as the top five schools. The state’s top 13 two-year schools were also ranked, with Trinidad State Junior College, Pueblo Community College, Aims Community College, Otero Junior College and Colorado Northwestern Community College taking the top five spots. “Colorado’s schools are becoming increasingly attuned to the needs of nontraditional students,” said Doug Jones, CEO and founder of AccreditedSchoolsOnline.org. “The accredited schools on our list accommodate all kinds of schedules with their online programs so that busy students can finish their degrees and receive a top-quality learning experience.” Schools on the “Best” list must meet specific base requirements to be included: each must be institutionally accredited, public or private not-for-profit. Each college was also scored based on more than a dozen additional data points, including student to teacher ratios, graduation rates and financial aid availability. For more details on where each school falls in the rankings and the data and methodology used to determine the lists, visit: Colorado’s Best Online Four-Year Schools for 2017 include the following: Adams State University Colorado Christian University Colorado Mesa University Colorado State University-Fort Collins Colorado State University-Global Campus Colorado State University-Pueblo Johnson & Wales University-Denver Metropolitan State University of Denver Nazarene Bible College Regis University University of Colorado Boulder University of Colorado Colorado Springs University of Colorado Denver University of Denver University of Northern Colorado Western State Colorado University Colorado’s Best Online Two-Year Schools for 2017 include the following: Aims Community College Arapahoe Community College Colorado Northwestern Community College Community College of Aurora Community College of Denver Front Range Community College Lamar Community College Morgan Community College Northeastern Junior College Otero Junior College Pikes Peak Community College Pueblo Community College Trinidad State Junior College About Us: AccreditedSchoolsOnline.org was founded in 2011 to provide students and parents with quality data and information about pursuing an affordable, quality education that has been certified by an accrediting agency. Our community resource materials and tools span topics such as college accreditation, financial aid, opportunities available to veterans, people with disabilities, as well as online learning resources. We feature higher education institutions that have developed online learning programs that include highly trained faculty, new technology and resources, and online support services to help students achieve educational success.
News Article | December 5, 2016
The International Association of HealthCare Professionals is pleased to welcome Harold J. Wanebo, MD, FACS, Surgical Oncologist, to their prestigious organization with his upcoming publication in The Leading Physicians of the World. He is a highly trained and qualified surgical oncologist with a vast expertise in all facets of his work. Dr. Wanebo has been in practice for more than 42 years and is currently serving patients in Private Practice and at Roger Williams Medical Center in Woonsocket, Rhode Island. Dr. Wanebo graduated with his Medical Degree in 1961 from the University of Colorado Denver School of Medicine. Following his graduation, Dr. Wanebo interned at Cornell University, served his surgery residency at the University of California, San Francisco, before his Tumor Immunology residency at Memorial Sloan Kettering Cancer Center. Dr. Wanebo board certified in General Surgery by the American Board of Surgery, and keeps up to date with the latest advances in his field through his professional memberships with the American Head and Neck Society, the Society of Surgical Oncology, and the American Society of Clinical Oncology. Dr. Wanebo is the creator of the University of Virginia Surgical Oncology Program, and has earned the coveted title of Fellow of the American College of Surgeons. He attributes his great success to the support from his wife and his love for medicine. When he is not assisting patients, Dr. Wanebo enjoys skiing, playing the piano, and cancer research. Learn more about Dr. Wanebo by reading his upcoming publication in The Leading Physicians of the World. FindaTopDoc.com is a hub for all things medicine, featuring detailed descriptions of medical professionals across all areas of expertise, and information on thousands of healthcare topics. Each month, millions of patients use FindaTopDoc to find a doctor nearby and instantly book an appointment online or create a review. FindaTopDoc.com features each doctor’s full professional biography highlighting their achievements, experience, patient reviews and areas of expertise. A leading provider of valuable health information that helps empower patient and doctor alike, FindaTopDoc enables readers to live a happier and healthier life. For more information about FindaTopDoc, visit:http://www.findatopdoc.com
News Article | October 29, 2016
AffordableCollegesOnline.org, a leading online higher education information and resource provider, is highlighting 25 schools as the Best Online Colleges in Colorado for 2016-2017. Comparing more than a dozen unique cost and quality measures, the following two-year and four-year schools received top marks respectively: Lamar Community College, Colorado Northwestern Community College, Trinidad State Junior College, Northeastern Junior College and Morgan Community College; Colorado Christian University, University of Northern Colorado, University of Colorado – Colorado Springs, Adams State University and Metropolitan State University of Denver. "In 2014 alone, non-residents made up nearly half of all four-year college applicants in Colorado. That shows a growing opportunity for distance and online learning programs in the state,” said Dan Schuessler, CEO and Founder of AffordableCollegesOnline.org. "We’re highlighting colleges who are going above and beyond to create quality, affordable online programs to accommodate the growing number of students looking to Colorado for higher education resources.” Schools are required to meet specific baseline requirements to make the AffordableCollegesOnline.org lists. An institution must hold regional accreditation and be a public or private not-for-profit college or university to qualify. Tuition rates must also fall under specific minimums: two-year schools must offer an in-state tuition rate below $5,000 per year and four-year schools must offer an in-state tuition rate below $25,000 per year. All schools on the Best Online Colleges in Colorado ranking are listed below. For more details on where each ranks and the data and methodology used to determine each school’s score visit the following page: The Best Online Colleges in Colorado (Two-Year) for 2016-2017: The Best Online Colleges in Colorado (Four-Year) for 2016-2017: Colorado Christian University University of Northern Colorado University of Colorado, Colorado Springs Adams State University Metropolitan State University of Denver University of Colorado Denver Colorado State University - Fort Collins Western State Colorado University Nazarene Bible College Colorado Mesa University Colorado State University - Global Campus Colorado State University - Pueblo AffordableCollegesOnline.org began in 2011 to provide quality data and information about pursuing an affordable higher education. Our free community resource materials and tools span topics such as financial aid and college savings, opportunities for veterans and people with disabilities, and online learning resources. We feature higher education institutions that have developed online learning environments that include highly trained faculty, new technology and resources, and online support services to help students achieve educational and career success. We have been featured by nearly 1,100 postsecondary institutions and nearly 120 government organizations.
News Article | October 28, 2015
Researchers on social media have been split by the decision of academic librarian Jeffrey Beall to add the Frontiers journals to his ‘blacklist’ of “questionable publishers”. Beall, at the University of Colorado Denver, announced the move in a tweet: His website Scholarly Open Access maintains a list of journals that may be “predatory publishers" — a term Beall coined to cover publications that charge scientists fees to publish research papers, but that do not offer standard publishing services such as peer review or that make misleading claims about their journals on issues such as impact factors or indexing. Critics spoke out against Beall’s blacklisting of Frontiers, maintaining that the open-access publisher is legitimate and reputable and does offer proper peer review. Daniël Lakens, an experimental psychologist at the Eindhoven University of Technology in the Netherlands and an associate editor at Frontiers in Cognition, tweeted: Beall told Nature that he stands by his decision and that he has received dozens of e-mails from the scientific community outlining bad practices at Frontiers. Beall names some controversies that he says helped raise concerns about the Frontiers journals. These include a Frontiers in Psychology paper suggesting that conspiracy theorists do not believe in climate change and a Frontiers in Public Health paper raising questions about the link between HIV and AIDS. Both ignited Internet firestorms on publication. In a statement, Frontiers said that it was committed to serving the academic community, was a member of the Committee on Publication Ethics and was also on the ‘whitelist’ of legitimate publishers kept by the Directory of Open Access Journals. “Dubious actions as such by an individual with a long history of opposing Open Access publishing serve only to create confusion that slows down the development of Open Access publishing,” says the statement. Adding Frontiers to the blacklist may cause problems for researchers who have previously published in the journals, says Lakens. "It could be, the articles people have published in Frontiers are no longer judged based on their own quality, but are now seen as less valuable because Frontiers is on Beall’s list," he says. "Having a single influential individual cast doubt on such a huge journal feels very unfair.” Love it or hate it, Beall's blacklist is the only one out there, and it's providing an important service, says Neuroskeptic, a pseudonymous neuroscience blogger and researcher in the United Kingdom. Although he doesn’t agree with Beall’s decision, Neuroskeptic says that he sees the value and merit of the Scholarly Open Access website. "The grand majority of these publishers really are seriously dodgy, and someone needs to be calling them out," Neuroskeptic says. "The list has helped me — I think it’s important." The Holtzbrinck Group, based in Stuttgart, Germany, is a part owner of Frontiers and also owns a share of Nature’s parent company, Springer Nature. Frontiers says that “While generally operating as an independent business and publisher, Frontiers now collaborates with Holtzbrinck businesses including NPG on key initiatives to advance the cause of Open Science for the benefit of both the research community and the broader public.” Nature’s news team is editorially independent.
News Article | November 29, 2016
The International Association of HealthCare Professionals is proud to welcome Dr. Jason A. Hicks, MD, to their esteemed organization with an upcoming publication in The Leading Physicians of the World. Dr. Hicks is a pathologist, who specializes in anatomic pathology and clinical pathology at Rocky Mountain Pathology Consultants in Denver, Colorado. With 18 years of experience in a variety of settings, such as large, multi-hospital system, surgery centers, small hospitals, and reference laboratories, Dr. Hicks has been successful in his practice. Dr. Hicks, a Colorado native, earned his medical degree from the University of Colorado Denver in 1998. Since then, he has received the Gary Miller, MD, PhD Award for Research as Surgical Path fellow at the University of Colorado Health Science Center, as well as teaching awards at the same college. He is a past president of the Colorado Society of Clinical Pathologists, and volunteers medical services for local schools. He accredits his success to making himself available to physicians in the community and the depth of his knowledge. View Dr. Jason A. Hicks’ Profile Here: https://www.findatopdoc.com/doctor/Jason-Hicks-Pathologist-CO-80237 and look for his publication in The Leading Physicians of the World. FindaTopDoc.com is a hub for all things medicine, featuring detailed descriptions of medical professionals across all areas of expertise, and information on thousands of healthcare topics. Each month, millions of patients use FindaTopDoc to find a doctor nearby and instantly book an appointment online or create a review. FindaTopDoc.com features each doctor’s full professional biography highlighting their achievements, experience, patient reviews and areas of expertise. A leading provider of valuable health information that helps empower patient and doctor alike, FindaTopDoc enables readers to live a happier and healthier life. For more information about FindaTopDoc, visit http://www.findatopdoc.com